Mielóma multiplex: vizsgálatok itt: Ausztrália
51 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
- Where
- Adelaide, Coffs Harbour, Fitzroy, Melbourne, Port Macquarie, South Brisbane, Westmead, West Perth
- Életkor
- 18 év to 64 év
- People
- 602 worldwide
- Run by
- AbbVie
See details and how to joinNCT06892522 · EU 2024-515770-27-00 - 2. fázisCsak meghívásosInternational Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
- Where
- Blacktown, Heidelberg, Melbourne, Richmond, Saint Leonards, Wollongong
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Sanofi
See details and how to joinNCT05669989 - 1/2. fázisTaking peopleA Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Camperdown, East Melbourne
- Életkor
- 18 év and over
- People
- 101 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07681596 - 2. fázisTaking peopleStudy of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Brisbane, Camperdown, Melbourne
- Életkor
- 18 év and over
- People
- 230 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06297226 - 3. fázisTaking peopleA Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
- Where
- Camperdown, Darlinghurst, Fitzroy, Liverpool, Melbourne, Murdoch
- Életkor
- 18 év and over
- People
- 508 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07391657 - 3. fázisTaking peopleA Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Darlinghurst, Garran, Heidelberg, Macquarie University, Melbourne, Perth, Port Macquarie
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07518186 - 1. fázisTaking peopleA Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
- Where
- Perth
- Életkor
- 18 év and over
- People
- 258 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT07477587 - 1. fázisTaking peopleA Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
- Where
- Camperdown, Melbourne
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Kelonia Therapeutics, Inc.
See details and how to joinNCT07075185 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- Where
- Benowa, Clayfield, East Melbourne, Fitzroy, Geelong, Greenslopes, Melbourne, Perth, Richmond, Woolloongabba
- Életkor
- 18 év and over
- People
- 893 worldwide
- Run by
- Pfizer
See details and how to joinNCT05020236 · EU 2023-509208-14-00 - 1/2. fázisTaking peopleA Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
- Where
- Fitzroy, Nedlands
- Életkor
- 18 év and over
- People
- 123 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05714839 · EU 2022-501941-63-00 - 3. fázisTaking peopleStudy of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
- Where
- Concord, Darlinghurst, East Melbourne, Fitzroy, Liverpool, Melbourne, Murdoch, Waratah
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07764978 - 1/2. fázisTaking peopleA Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma
- Where
- Adelaide, Benowa, Melbourne, Sydney, Wollongong
- Életkor
- 18 év and over
- People
- 186 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06669247 · EU 2024-513126-39-00 - 4. fázisTaking peopleElranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
- Where
- Melbourne, Richmond
- Életkor
- 18 év and over
- People
- 80 worldwide
- Run by
- Pfizer
See details and how to joinNCT06057402 · EU 2023-505200-33-00 - 1. fázisTaking peopleAutologous Chimeric Antigen Receptor (CAR) T-cells Targeting the Kappa Myeloma Antigen (KMA) in Kappa Restricted Multiple Myeloma Patients With Relapsed/Refractory Disease
- Where
- Melbourne
- Életkor
- 18 év and over
- People
- 12
- Run by
- Peter MacCallum Cancer Centre, Australia
See details and how to joinNCT07541391 - 1. fázisTaking peopleStudy of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Blacktown, Melbourne, Nedlands, Wollongong
- Életkor
- 18 év and over
- People
- 135 worldwide
- Run by
- AbbVie
See details and how to joinNCT06896916 · EU 2024-512146-41-00 - 3. fázisTaking peopleA Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- Where
- Box Hill, Fitzroy, Gosford NSW, Herston, Melbourne, St Leonards
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06679101 · EU 2024-516030-35-00 - 1. fázisTaking peopleStudy of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
- Where
- Benowa, Concord, Fitzroy, Melbourne, Nedlands
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Ichnos Sciences SA
See details and how to joinNCT05862012 · EU 2023-507071-21-01 - 1. fázisTaking peopleA Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
- Where
- Melbourne, Wollongong
- Életkor
- 18 év and over
- People
- 87 worldwide
- Run by
- Sanofi
See details and how to joinNCT06630806 - 3. fázisTaking peopleA Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
- Where
- Adelaide, Box Hill, Canberra, Geelong, Heidelberg, Kingswood, Melbourne, Sunshine Coast
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to joinNCT06932562 · EU 2024-519827-16-00 - No phaseTaking peopleEuropean Myeloma Network (EMN) Sample Project
- Where
- Melbourne
- Életkor
- 18 év and over
- People
- 6000 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to joinNCT06237803 - 2/3. fázisTaking peopleRole of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
- Where
- Adelaide, Melbourne
- Életkor
- 18 év and over
- People
- 900
- Run by
- Monash University
See details and how to joinNCT07202052 - 2/3. fázisTaking peopleRole of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
- Where
- Adelaide, Melbourne
- Életkor
- 18 év and over
- People
- 900
- Run by
- Monash University
See details and how to joinNCT07202065 - 2/3. fázisTaking peopleRole of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
- Where
- Adelaide, Melbourne
- Életkor
- 18 év and over
- People
- 900
- Run by
- Monash University
See details and how to joinNCT07202078 - 2/3. fázisTaking peopleRole of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)
- Where
- Adelaide, Melbourne
- Életkor
- 18 év and over
- People
- 900
- Run by
- Monash University
See details and how to joinNCT07202091 - 1/2. fázisFelfüggesztveA Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
- Where
- Heidelberg, Melbourne, Wollongong
- Életkor
- 18 év and over
- People
- 116 worldwide
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT06083207